相似文献
1
Ferumoxytol-enhanced MR Venography of Central Veins: Commentary.
Radiol Cardiothorac Imaging. 2020 Nov 19;2(6):e200557. doi: 10.1148/ryct.2020200557. eCollection 2020 Dec.
2
Ferumoxytol-enhanced MR Venography of the Central Veins of the Thorax for the Evaluation of Stenosis and Occlusion in Patients with Renal Impairment.
Radiol Cardiothorac Imaging. 2020 Nov 19;2(6):e200339. doi: 10.1148/ryct.2020200339. eCollection 2020 Dec.
3
Ferumoxytol-enhanced MR venography for diagnosis of venous thoracic outlet syndrome.
Radiol Case Rep. 2023 Apr 29;18(7):2378-2380. doi: 10.1016/j.radcr.2023.03.052. eCollection 2023 Jul.
4
High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion.
J Cardiovasc Magn Reson. 2019 Mar 11;21(1):17. doi: 10.1186/s12968-019-0528-5.
5
Deep venous thrombosis: diagnosis by using venous enhanced subtracted peak arterial MR venography versus conventional venography.
Radiology. 2003 Mar;226(3):812-20. doi: 10.1148/radiol.2263012205. Epub 2003 Jan 24.
6
High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol.
Pediatr Radiol. 2022 Mar;52(3):501-512. doi: 10.1007/s00247-021-05225-2. Epub 2021 Dec 22.
7
A three-dimensional gadolinium-enhanced MR venography technique for imaging central veins.
AJR Am J Roentgenol. 1999 Oct;173(4):999-1003. doi: 10.2214/ajr.173.4.10511166.
8
Three-dimensional gadolinium-enhanced MR venographic evaluation of patency of central veins in the thorax: initial experience.
Radiology. 1999 Nov;213(2):555-60. doi: 10.1148/radiology.213.2.r99nv27555.
9
Ferumoxytol MR Angiography versus Duplex US for Vascular Mapping before Arteriovenous Fistula Surgery for Hemodialysis.
Radiology. 2020 Oct;297(1):214-222. doi: 10.1148/radiol.2020200069. Epub 2020 Jul 21.
10
Recurrent lower-limb varicose veins: effect of direct contrast-enhanced three-dimensional MR venographic findings on diagnostic thinking and therapeutic decisions.
Radiology. 2008 Jun;247(3):887-95. doi: 10.1148/radiol.2473070987. Epub 2008 Apr 10.
本文引用的文献
1
Ferumoxytol-enhanced MR Venography of the Central Veins of the Thorax for the Evaluation of Stenosis and Occlusion in Patients with Renal Impairment.
Radiol Cardiothorac Imaging. 2020 Nov 19;2(6):e200339. doi: 10.1148/ryct.2020200339. eCollection 2020 Dec.
2
Ferumoxytol MR Angiography versus Duplex US for Vascular Mapping before Arteriovenous Fistula Surgery for Hemodialysis.
Radiology. 2020 Oct;297(1):214-222. doi: 10.1148/radiol.2020200069. Epub 2020 Jul 21.
3
Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI.
Radiology. 2019 Dec;293(3):554-564. doi: 10.1148/radiol.2019190477. Epub 2019 Oct 22.
4
High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion.
J Cardiovasc Magn Reson. 2019 Mar 11;21(1):17. doi: 10.1186/s12968-019-0528-5.
5
Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol.
Pediatr Radiol. 2016 Aug;46(9):1332-40. doi: 10.1007/s00247-016-3605-z. Epub 2016 Apr 8.
6
Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy.
Radiology. 2015 Jul;276(1):228-32. doi: 10.1148/radiol.2015142690. Epub 2015 May 5.
7
Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases.
J Magn Reson Imaging. 2014 Jul;40(1):113-8. doi: 10.1002/jmri.24330. Epub 2013 Oct 15.
8
Three-dimensional gadolinium-enhanced MR venographic evaluation of patency of central veins in the thorax: initial experience.
Radiology. 1999 Nov;213(2):555-60. doi: 10.1148/radiology.213.2.r99nv27555.
Zotero 插件